000 01306 a2200373 4500
005 20250517063732.0
264 0 _c20161108
008 201611s 0 0 eng d
022 _a1432-1076
024 7 _a10.1007/s00431-015-2670-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBonnot, O
245 0 0 _aPsychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
_h[electronic resource]
260 _bEuropean journal of pediatrics
_cJan 2016
300 _a9-18 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAdolescent
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCystine
_xanalogs & derivatives
650 0 4 _aFructose
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aPrader-Willi Syndrome
_xdrug therapy
650 0 4 _aPsychotropic Drugs
_xtherapeutic use
650 0 4 _aRisperidone
_xtherapeutic use
650 0 4 _aTopiramate
700 1 _aCohen, D
700 1 _aThuilleaux, D
700 1 _aConsoli, A
700 1 _aCabal, S
700 1 _aTauber, M
773 0 _tEuropean journal of pediatrics
_gvol. 175
_gno. 1
_gp. 9-18
856 4 0 _uhttps://doi.org/10.1007/s00431-015-2670-x
_zAvailable from publisher's website
999 _c25463805
_d25463805